Epstein-Barr Virus Infections
Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).
Subtype terms (3)
More specific conditions that are subtypes of Epstein-Barr Virus Infections in the MeSH hierarchy.
- Burkitt Lymphoma
171 drugs (99 approved, 72 experimental)
- Infectious Mononucleosis
10 drugs (4 approved, 6 experimental)
- Leukoplakia, Hairy
1 drug approved
Drugs by status
Approved for this indication (1)
Phase 4 trials (4)
Phase 3 trials (10)
Phase 2 trials (30)
- cmv-specific t-cells
- autologous ebv specific cytotoxic t lymphocytes
- brentuximab vedotin
- durvalumab
- tenofovir
- epacadostat
- nivolumab
- pembrolizumab
- allogeneic hematopoietic stem cells
- valaciclovir
- valganciclovir
- bortezomib
- capecitabine
- autologous cmv-specific ctl
- ebv vaccine (268664)
- recombinant epstein-barr virus vaccine
- trivirus specific ctls for ebv, cmv and adenovirus infection
- cytotoxic t cells
- adenovirus-specific t-cells
- sintilimab
- tabelecleucel
- chidamide
- virus-specific T cells
- matrix m1
- Nanatinostat
- cmv/adv /ebv/bkv specific t cells
- ebv-tcr-t cells
- EBV Specific T-Lymphocytes
- ebv gp350-ferritin vaccine
- star0602
Phase 1 trials (18)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (31)
- Seattle Genetics
- Millennium Pharmaceuticals
- Merck
- Atara Biotherapeutics
- Epiphany Biosciences
- The EMMES Corporation
- National Heart, Lung, and Blood Institute (NHLBI)
- National Marrow Donor Program
- Maisonneuve-Rosemont Hospital
- University of Pennsylvania
- University of Pittsburgh
- Baylor University
- Harvard University
- Duke University
- Medical College of Wisconsin
- New York Medical College
- Northwestern University
- Rutgers University
- Shenzhen Geno-Immune Medical Institute
- University of Miami
- University of Southern California
- University of Toronto
- Chinese University of Hong Kong
- University of California, Los Angeles
- University of Minnesota
- University of Montreal
- University of Texas at Houston
- Methodist Cancer Center, Houston, Texas
- Children's National Medical Center
- Blood and Marrow Transplant Clinical Trials Network
- +1 more
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)